The underlying bullish trend remains intact, as prices post new highs. Momentum studies are already overstretched, however, but downside risks are likely to remain limited as monthly studies remain strong and investors maintain a buy-into-dips strategy.
JP Morgan is also outperforming the SP500, and as a proxy for the broader based US Financials Sector, asset ...